Autopsy report · NCT00964834

Ph1 Study of Valortim and Doxycycline in Humans

“Sister trial has SAE investigation underway - sponsor elected to withdraw as study expected to be repeated later”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 month after it had already started.
• Ran for about 5 months before it stopped.
• 24 participants planned (an estimate, not an actual count).
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 1

Sponsor

PharmAthene, Inc.

Sponsor type

Industry

Conditions

Anthrax

Interventions

Doxycycline and Valortim; Placebo Antibiotic and Valortim; Placebo Antibiotic and Placebo Valortim

Participants

24 (planned, not actual)

Sites

1

Countries

United States

Trials that died the same way

• A Prospective Longitudinal Collection of Subjects Diagnosed With Small Cell Lung Cancer
  “Decision was made by Sponsor to stop the trial.” (63% match in meaning)
• Navelbine, Taxol, Herceptin and Neupogen in Stage IV Breast Cancer: A Phase I - II Trial
  “Sponsor withdrew the study” (63% match in meaning)
• NRX-1074 in Early Course Schizophrenia
  “The study was withdrawn by the sponsor.” (62% match in meaning)
• A Study of mRNA-1647 Cytomegalovirus Vaccine in Liver Transplant Candidates and Recipients
  “Trial was cancelled by Sponsor” (62% match in meaning)
• Community-based Nutrition Program Effectiveness Evaluation in Afghanistan
  “Funding for the study withdrawn by sponsor after baseline data collected” (62% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.